Sean Pitroda to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications Sean Pitroda has written about Xenograft Model Antitumor Assays.
Connection Strength
0.259
-
JAK2 Inhibitor SAR302503 Abrogates PD-L1 Expression and Targets Therapy-Resistant Non-small Cell Lung Cancers. Mol Cancer Ther. 2018 04; 17(4):732-739.
Score: 0.135
-
Basal Tumor Cell Isolation and Patient-Derived Xenograft Engraftment Identify High-Risk Clinical Bladder Cancers. Sci Rep. 2016 10 24; 6:35854.
Score: 0.124